Do Patients on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Require Longer Fasting Prior to Vibration Controlled Transient Elastography?
Refinessuggested applicable standard· Gorgojo-Martínez JJ, et al. 'Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with GLP-1 Receptor Agonists: A Multidisciplinary Expert Consensus,' Journal of Clinical Medicine, 2022
Decision at stakefasting duration before vibration controlled transient elastography in patients on GLP-1 receptor agonists
Manage GLP-1 receptor agonist GI symptoms with slow titration per package insert, dietary modification (small frequent meals, low-fat, low-fiber initially, avoid alcohol), and hydration; treat nausea with PRN ondansetron and consider dose reduction, constipation with hydration/fiber/PEG, and reflux with an H2 blocker or PPI. …
From our summary of this standard, unedited — the part the paper bears on. … marks omitted text. Our wording, not the guideline's; read the source for its own text.
Our full summary of this standard
Manage GLP-1 receptor agonist GI symptoms with slow titration per package insert, dietary modification (small frequent meals, low-fat, low-fiber initially, avoid alcohol), and hydration; treat nausea with PRN ondansetron and consider dose reduction, constipation with hydration/fiber/PEG, and reflux with an H2 blocker or PPI. Discontinue the drug for severe persistent nausea/vomiting, suspected acute pancreatitis, or severe weight loss with malnutrition, and evaluate red-flag presentations for pancreatitis, obstruction/ileus, or failure to thrive; for suspected gallbladder disease (cholelithiasis/cholecystitis), obtain gallbladder studies and clinical follow-up rather than mandatory discontinuation. Do not routinely check lipase; hold and evaluate only if symptoms suggest pancreatitis.